Literature DB >> 18268070

Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction.

E Jeffrey Metter1, B Gwen Windham, Marcello Maggio, Eleanor M Simonsick, Shari M Ling, Josephine M Egan, Luigi Ferrucci.   

Abstract

OBJECTIVE: To verify what information from oral glucose tolerance tests (OGTTs) independently predicts mortality. RESEARCH DESIGN AND METHODS: A total of 1,401 initially nondiabetic participants from the Baltimore Longitudinal Study of Aging aged 17-95 years underwent one or more OGTTs (median 2, range 1-8), with insulin and glucose measurements taken every 20 min over the course of 2 h included in this study. Proportional hazards using the longitudinally collected data and Bayesian model averaging were used to examine the association of OGTT measurements individually and grouped with mortality, adjusting for covariates.
RESULTS: Participants were followed for a median 20.3 years (range 0.5-40). The first-hour OGTT glucose and insulin levels increased only modestly with age, whereas levels during the second hour increased 4% per decade. Individually, 100- and 120-min glucose measures and fasting and 100-min insulin levels were all independent predictors of mortality. When all measures were considered together, only higher 120-min glucose was a significant independent risk factor for mortality.
CONCLUSION: The steeper rise with age of the OGTT 2-h glucose values and the prognostic primacy of the 120-min glucose value for mortality is consistent with previous reports and suggests the value of using the OGTT in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268070      PMCID: PMC2430037          DOI: 10.2337/dc07-2102

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

2.  Is there a glycemic threshold for mortality risk?

Authors:  B Balkau; S Bertrais; P Ducimetiere; E Eschwege
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

3.  Insulin response during the oral glucose tolerance test: the role of age, sex, body fat and the pattern of fat distribution.

Authors:  D C Muller; D Elahi; J D Tobin; R Andres
Journal:  Aging (Milano)       Date:  1996-02

4.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 5.  The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.

Authors:  John D Sorkin; Denis C Muller; Jerome L Fleg; Reubin Andres
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

6.  Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.

Authors:  S H Wild; F B Smith; A J Lee; F G R Fowkes
Journal:  Diabet Med       Date:  2005-04       Impact factor: 4.359

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.

Authors: 
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

9.  Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

Authors:  Mattie Lenzen; Lars Ryden; John Ohrvik; Malgorzata Bartnik; Klas Malmberg; Wilma Scholte Op Reimer; Maarten L Simoons
Journal:  Eur Heart J       Date:  2006-11-07       Impact factor: 29.983

10.  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Authors:  A Mari; G Pacini; E Murphy; B Ludvik; J J Nolan
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

View more
  20 in total

1.  Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults.

Authors:  Richard D Semba; Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Olga D Carlson; Mohammed Khadeer; Chee W Chia; Norman Salem; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

2.  Glucose and insulin measurements from the oral glucose tolerance test and relationship to muscle mass.

Authors:  Rita R Kalyani; E Jeffrey Metter; Ramona Ramachandran; Chee W Chia; Christopher D Saudek; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-24       Impact factor: 6.053

Review 3.  Atherosclerotic cardiovascular disease in older adults with diabetes mellitus.

Authors:  Joshua I Barzilay; Kenneth J Mukamal; Jorge R Kizer
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

4.  Frailty status and altered glucose-insulin dynamics.

Authors:  Rita Rastogi Kalyani; Ravi Varadhan; Carlos O Weiss; Linda P Fried; Anne R Cappola
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-26       Impact factor: 6.053

Review 5.  Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.

Authors:  Chee W Chia; Josephine M Egan; Luigi Ferrucci
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 6.  Diabetes and altered glucose metabolism with aging.

Authors:  Rita Rastogi Kalyani; Josephine M Egan
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-22       Impact factor: 4.741

7.  Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging.

Authors:  Madhav Thambisetty; Lori L Beason-Held; Yang An; Michael Kraut; Jeffrey Metter; Josephine Egan; Luigi Ferrucci; Richard O'Brien; Susan M Resnick
Journal:  Neurobiol Aging       Date:  2013-04-19       Impact factor: 4.673

8.  HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.

Authors:  E L M Barr; A J Cameron; B Balkau; P Z Zimmet; T A Welborn; A M Tonkin; J E Shaw
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

9.  Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.

Authors:  Madhav Thambisetty; E Jeffrey Metter; An Yang; Hillary Dolan; Christopher Marano; Alan B Zonderman; Juan C Troncoso; Yun Zhou; Dean F Wong; Luigi Ferrucci; Josephine Egan; Susan M Resnick; Richard J O'Brien
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 10.  Interventions for Human Frailty: Physical Activity as a Model.

Authors:  Linda P Fried
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.